Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion type Assertion NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_head.
- NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion description "[However, BCL2A1 is overexpressed in a variety of cancer cells, including hematological malignancies and solid tumors, and may contribute to tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_provenance.
- NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion evidence source_evidence_literature NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_provenance.
- NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion SIO_000772 22075983 NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_provenance.
- NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion wasDerivedFrom befree-20140225 NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_provenance.
- NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_assertion wasGeneratedBy ECO_0000203 NP895511.RArAt2XkrcboWTIffUoE11br0GWFFPcF9sz2syWd-hMnU130_provenance.